Altered Purinergic Signaling and CD8+ T Cell Dysregulation in STAT3 GOF Syndrome
Jose S. Campos, Montana Knight, Samir U. Sayed, Megan C. Dalalo, Andrea Alexis Mauracher, Peyton E. Conrey, Aaron B. Schultz, Ceire A. Hay, Robert B. Lindell, Ilona Neale, Kyle Yeakle, Eric D. Abrams, Erica G. Schmitt, Martin A. Thelin, Christian A. Howard, , Sarah Emily Henrickson
This study identifies altered purinergic signaling and CD8+ T cell dysregulation in STAT3 GOF syndrome, showing partial normalization with JAK inhibitors.
JCI Insight · Sep 7, 2026Peer-reviewedImmunology